75 compounds to support ongoing covid-19 research
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00278
- Awardee
-
Medchemexpress LLC UEI EWMQQNKJ3YZ8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $113,163
Award facts
- Opportunity
-
- 75 Compounds to Support Ongoing COVID-19 Research Solicitation · 75N95022Q00218 · Posted May 2, 2022
- Contract value 100% obligated
- $113,163.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $113,163 |
About this award
This $113,163 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, peptides, and other life science research materials. The contract is for the delivery of 75 chemical compounds to support ongoing COVID-19 research. The award was made via a purchase order under a non-competitive combined synopsis/solicitation process, with a completion date of December 31, 2022. No set-aside designation was used for this contract. MedChemExpress has previously provided scientific inputs and chemical reagents to NIH and its sub-components through both prime and subcontractor roles.
Quick answers
Who was awarded contract 75N95022P00278?
75N95022P00278 was awarded to Medchemexpress LLC by National Institute on Drug Abuse (National Institutes of Health) on May 17, 2022.
How much is contract 75N95022P00278 worth?
The government has obligated $113,163 on 75N95022P00278.
Which agency awarded contract 75N95022P00278?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00278, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95022P00278 competed?
The extent of competition for 75N95022P00278 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award